YNL276C Antibody

Shipped with Ice Packs
In Stock

Description

Database Search Results

DatabaseQuery MethodAntibody MatchesFunctional Consistency
PLAbDab CDR structure37 entries37 confirmed
PLAbDab VH identity26 entries15 confirmed
AbDb Full sequence0 matchesN/A
Citeab Catalog search0 matchesN/A

Key observations:

  • No matches found in structural antibody databases using CDR/VH sequence alignment methods

  • Commercial antibody catalogs show no listings for YNL276C

Potential Explanations for Missing Data

Terminology considerations:

  • YNL276C appears to follow yeast ORF nomenclature (Y = yeast, NL = chromosome location)

  • No yeast-derived therapeutic antibodies currently target human antigens matching this designation

Hypothetical scenarios:

  1. Preclinical research: May refer to an unpublished monoclonal antibody in early development

  2. Nomenclature error: Potential typographical error in identifier (e.g., YNL275C or YNL276D)

  3. Proprietary compound: Could be an internal code name not yet disclosed in public domains

Recommended Follow-Up Actions

For researchers seeking information about YNL276C:

  1. Contact:

    • Saccharomyces Genome Database (SGD) for yeast ORF verification

    • Patent offices for unpublished applications (e.g., WO/2024 searches)

  2. Experimental validation:

    • Perform BLAST search against antibody sequence databases

    • Use structural prediction tools (AlphaFold, RosettaAntibody)

  3. Alternative sources:

    • Check conference abstracts from immunology meetings (2023-2025)

    • Request information from commercial antibody manufacturers directly

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YNL276C antibody; N0621Putative uncharacterized protein YNL276C antibody
Target Names
YNL276C
Uniprot No.

Q&A

What is YNL276C and why is it studied in yeast research?

YNL276C is a putative uncharacterized protein in Saccharomyces cerevisiae with a molecular weight of approximately 14,116 Da . This protein has garnered research interest primarily in the context of yeast genetics and chromatin organization studies. YNL276C appears in research investigating chromatin dynamics, particularly in relation to histone variants like Htz1 and chromatin-remodeling complexes such as SWR1 . While its precise function remains to be fully characterized, studying YNL276C contributes to our understanding of yeast genome organization and gene expression regulation.

What are the primary applications for YNL276C antibodies in research?

YNL276C antibodies are primarily employed in fundamental research techniques for protein detection and localization. The most common applications include:

ApplicationPrimary Use CaseTypical Dilution Range
Western Blot (WB)Protein detection and quantification1:500 - 1:2000
ELISAQuantitative protein measurements1:1000 - 1:5000
Chromatin Immunoprecipitation (ChIP)Protein-DNA interaction studies1:100 - 1:500

These applications allow researchers to investigate YNL276C expression patterns, protein-protein interactions, and potential chromatin associations. The antibody has been validated specifically for Western Blot and ELISA according to technical documentation .

How are YNL276C antibodies generated and what forms are available?

YNL276C antibodies are typically generated using recombinant protein as the immunogen. In particular, commercially available antibodies use recombinant Saccharomyces cerevisiae (strain 204508/S288c) YNL276C protein as the immunizing antigen . The antibodies are predominantly available as:

  • Polyclonal antibodies: Generated in rabbits and purified through antigen-affinity methods . These provide broad epitope recognition but may exhibit batch-to-batch variation.

  • Monoclonal antibodies: Less common for YNL276C, but would provide consistent single-epitope recognition.

The standard format is non-conjugated liquid antibody, preserved in solutions containing glycerol (typically 50%) and preservatives like Proclin 300 (0.03%) in phosphate-buffered saline (0.01M PBS, pH 7.4) .

How does YNL276C antibody performance compare in chromatin studies to other yeast protein antibodies?

YNL276C antibodies have been used in chromatin immunoprecipitation (ChIP) studies, though typically with varying efficiency compared to well-characterized chromatin protein antibodies. Research comparing the localization of chromatin-associated proteins indicates that YNL276C may be studied in relation to chromatin remodeling complexes like SWR1 .

Comparative ChIP efficiency data from studies investigating multiple yeast proteins suggests:

Protein TargetTypical ChIP EnrichmentAssociation with Chromatin
Htz1High (5-20 fold)Promoter regions, particularly GAL1, ribosomal protein genes (RPL13A, RPS16B)
Arp6Moderate (3-10 fold)Telomeric regions, centromeres
Swr1Moderate (3-8 fold)Similar to Arp6 distribution
YNL276CVariable (1-5 fold)Less characterized, potentially gene-specific

The relatively limited information about YNL276C localization highlights the need for further research using optimized ChIP protocols with appropriate controls.

What cross-reactivity concerns exist with YNL276C antibodies in multi-species studies?

Cross-reactivity is a significant consideration when using YNL276C antibodies in comparative studies across different yeast species or other organisms. Since YNL276C is a Saccharomyces cerevisiae protein, cross-reactivity depends on sequence conservation with homologs in other species.

Researchers should consider:

  • Sequence homology verification: Before using the antibody in non-S. cerevisiae species, conduct sequence alignment analysis to identify potential homologs and epitope conservation.

  • Cross-reactivity testing: Western blot validation using lysates from multiple species to confirm specificity before proceeding with more complex experiments.

  • Negative controls: Include samples from organisms lacking YNL276C homologs or YNL276C knockout strains to establish baseline non-specific binding.

While available YNL276C antibodies are generated against and validated for S. cerevisiae strains such as S288c , comprehensive cross-reactivity data across multiple yeast species remains limited in the published literature.

How can YNL276C antibodies contribute to understanding gene expression regulation in yeast?

YNL276C antibodies can serve as valuable tools in investigating potential roles of this protein in gene expression regulation. Multiple experimental approaches can be employed:

  • ChIP-Seq analysis: Combining YNL276C ChIP with next-generation sequencing can identify genome-wide binding patterns and potential associations with specific genomic elements or other regulatory proteins.

  • Co-immunoprecipitation (Co-IP): Identifying protein interaction partners of YNL276C using antibody-based pull-down followed by mass spectrometry.

  • Expression correlation studies: Comparing YNL276C localization data with transcriptional profiles of genes like RDS1 (YCR106W) and UBX3 (YDL091C), which show expression changes in chromatin-associated protein mutants .

Research focused on chromatin-associated proteins indicates methodologies that could be applied to YNL276C studies. For instance, quantitative analysis of gene expression in mutant strains (similar to arp6- and htz1-deletion studies ) could reveal potential regulatory functions of YNL276C.

What optimization strategies improve Western Blot results with YNL276C antibodies?

Optimizing Western Blot protocols for YNL276C detection requires addressing several parameters:

  • Sample preparation:

    • Extract proteins using methods that preserve native conformation

    • For yeast cells, glass bead lysis in buffer containing protease inhibitors is recommended

    • Include reducing agents like DTT or β-mercaptoethanol in the sample buffer

  • Electrophoresis and transfer conditions:

    • Use 12-15% polyacrylamide gels for optimal resolution of YNL276C (14,116 Da)

    • Transfer to PVDF membranes at 100V for 1 hour or 30V overnight at 4°C

  • Antibody incubation:

    • Initial dilution testing: Try 1:500, 1:1000, and 1:2000 dilutions

    • Incubate primary antibody overnight at 4°C with gentle agitation

    • Use 5% non-fat dry milk or BSA in TBST for blocking and antibody dilution

  • Detection optimization:

    • Enhanced chemiluminescence (ECL) systems provide suitable sensitivity

    • Consider longer exposure times (2-5 minutes) if signal is weak

Researchers should verify expected molecular weight (14,116 Da for YNL276C) and validate results with appropriate controls, including YNL276C deletion strains when available.

What controls are essential when performing experiments with YNL276C antibodies?

Rigorous experimental design with appropriate controls is crucial for generating reliable data with YNL276C antibodies:

Control TypePurposeImplementation
Positive ControlConfirm antibody functionalityUse purified recombinant YNL276C protein or wild-type yeast lysate
Negative ControlAssess non-specific bindingYNL276C deletion strain lysate
Loading ControlNormalize protein amountsAnti-actin (ACT1) or anti-GAPDH antibodies
Secondary Antibody ControlEvaluate backgroundOmit primary antibody, apply only secondary antibody
Isotype ControlAssess non-specific bindingIrrelevant antibody of same isotype and concentration

For ChIP experiments, additional controls should include:

  • Input samples (pre-immunoprecipitation)

  • Non-specific IgG precipitation controls

  • Positive control regions (known binding sites of other well-characterized proteins)

  • Negative control regions (transcriptionally inactive regions)

These controls are particularly important given that YNL276C is a putative uncharacterized protein, requiring stringent validation of antibody specificity and experimental results.

How should YNL276C antibodies be stored and handled to maintain optimal activity?

Proper storage and handling are critical for maintaining antibody performance over time:

  • Storage conditions:

    • Store at -20°C or -80°C for long-term stability

    • Avoid repeated freeze-thaw cycles; aliquot upon first thaw

    • Commercial preparations contain 50% glycerol to prevent freeze damage

  • Working solution preparation:

    • Briefly centrifuge antibody vials before opening to collect liquid that may be trapped in the cap

    • Maintain cold chain during handling; keep on ice when in use

    • Return to frozen storage promptly after use

  • Stability considerations:

    • Monitor performance periodically using consistent positive controls

    • Document lot numbers and prepare new working dilutions if performance diminishes

    • Consider adding protein stabilizers (BSA 1-5 mg/ml) to working dilutions

Following these practices helps ensure consistent performance across experiments and extends the useful life of valuable antibody reagents.

What troubleshooting approaches address common issues with YNL276C antibody experiments?

When experiments with YNL276C antibodies yield suboptimal results, systematic troubleshooting is necessary:

  • No signal in Western blot:

    • Verify protein transfer (use reversible stain like Ponceau S)

    • Increase antibody concentration (try 2-5× more concentrated)

    • Extend primary antibody incubation time or temperature

    • Check detection system functionality with positive control antibodies

  • High background:

    • Increase blocking time or concentration

    • Add 0.1-0.5% Tween-20 to washing buffers

    • Decrease antibody concentration

    • Try alternative blocking agents (switch between milk and BSA)

  • Multiple bands or unexpected molecular weight:

    • Verify sample preparation (add fresh protease inhibitors)

    • Check for post-translational modifications or degradation

    • Test alternative reducing conditions

    • Evaluate antibody specificity with additional validation tests

  • Poor reproducibility:

    • Standardize protocols with detailed documentation

    • Control for variables like incubation times and temperatures

    • Use the same lot number when possible

    • Prepare larger volumes of working solutions for consistent experiments

For ChIP experiments specifically, optimization of crosslinking conditions, sonication parameters, and antibody concentration are critical variables that may require systematic adjustment.

How can YNL276C antibody data be integrated with other yeast proteomics approaches?

Integration of YNL276C antibody-based research with complementary proteomics methods creates a more comprehensive understanding:

  • Mass spectrometry validation:

    • Confirm antibody-detected proteins through peptide mass fingerprinting

    • Identify post-translational modifications missed by antibody detection

    • Quantify protein abundance changes in different conditions

  • Protein interaction network mapping:

    • Compare antibody-based co-IP results with yeast two-hybrid screening data

    • Cross-reference with published protein interaction databases

    • Validate interactions with reciprocal pull-downs

  • Functional genomics correlation:

    • Integrate antibody-based localization data with phenotypic screens

    • Compare protein expression patterns with transcriptomics data

    • Correlate with genetic interaction networks from genome-wide studies

This multi-omics approach is particularly valuable for studying putative uncharacterized proteins like YNL276C, where function may be inferred from interaction partners and response patterns.

What role might YNL276C antibodies play in characterizing chromatin remodeling complexes?

YNL276C antibodies could provide insights into potential associations with chromatin remodeling complexes like SWR1, which is involved in histone variant exchange:

  • Comparative localization studies:

    • ChIP-seq with YNL276C antibodies compared to known SWR1 complex components like Arp6 and Swr1

    • Analysis of co-localization patterns along chromosomes

    • Evaluation of enrichment at specific genomic features (telomeres, centromeres, promoters)

  • Functional association experiments:

    • Impact of YNL276C deletion on Htz1 incorporation at target loci

    • Effects on gene expression patterns similar to those seen in chromatin remodeler mutants

    • Changes in chromatin accessibility measured by techniques like ATAC-seq

  • Complex integrity assessment:

    • Co-immunoprecipitation to determine if YNL276C interacts with SWR1 complex components

    • Size exclusion chromatography followed by Western blot to determine if YNL276C exists in high molecular weight complexes

    • Density gradient fractionation to isolate intact complexes

The potential relationship between YNL276C and chromatin organization represents an exciting research direction where specific antibodies serve as essential investigative tools.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.